Health-related quality of life overlooked in cancer drug studies - Medical Xpress

Medical XpressHealth-related quality of life overlooked in cancer drug studiesMedical XpressThe results were published today in the Journal of the American Medical Association (JAMA) Internal Medicine. "Given the increased use of progression-free survival as the primary outcome in new oncology drug trials, and uncertainty of overall survival, ...